These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 8738589)

  • 1. Protective effects of ticlopidine and aspirin, administered alone and in combination, on thrombus formation in rat cerebral vessels.
    Sasaki Y; Ishii I; Giddings JC; Yamamoto J
    Haemostasis; 1996; 26(3):150-6. PubMed ID: 8738589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antithrombotic effect of argatroban on the pial vessels of the rat: a study with He-Ne laser-induced thrombus formation.
    Sasaki Y; Morii S; Yamashita T; Yamamoto J
    Haemostasis; 1993; 23(2):104-11. PubMed ID: 8365687
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of a novel platelet nitric oxide donor (LA816), aspirin, clopidogrel, and combined therapy in inhibiting flow- and lesion-dependent thrombosis in the porcine ex vivo model.
    Vilahur G; Segalés E; Salas E; Badimon L
    Circulation; 2004 Sep; 110(12):1686-93. PubMed ID: 15381660
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antithrombotic effect of ticlopidine on He-Ne laser-induced thrombus formation in rat mesenteric microvessels.
    Yamamoto J; Ishii I; Sasaki Y; Nagamatsu Y; Matsuda T; Ando E
    Haemostasis; 1992; 22(3):147-52. PubMed ID: 1427459
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Early potent antithrombotic effect with combined aspirin and a loading dose of clopidogrel on experimental arterial thrombogenesis in humans.
    Cadroy Y; Bossavy JP; Thalamas C; Sagnard L; Sakariassen K; Boneu B
    Circulation; 2000 Jun; 101(24):2823-8. PubMed ID: 10859288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of combined administration of clopidogrel and lysine acetylsalicylate versus clopidogrel and aspirin on platelet aggregation and activated GPIIb/IIIa expression in healthy volunteers.
    Majluf-Cruz A; Chavez-Ochoa AR; Majluf-Cruz K; Coria-Ramirez E; Pineda Del Aguila I; Treviño-Perez S; Matías-Aguilar L; López-Armenta JC; Corona de la Peña N
    Platelets; 2006 Mar; 17(2):105-7. PubMed ID: 16421012
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unusual effects of aspirin on ticlopidine induced thrombolysis.
    Gryglewski RJ; Uracz W; Swieş J
    Thorax; 2000 Oct; 55 Suppl 2(Suppl 2):S17-9. PubMed ID: 10992548
    [No Abstract]   [Full Text] [Related]  

  • 8. Beneficial effect of CV-4151 (Isbogrel), a thromboxane A2 synthase inhibitor, in a rat middle cerebral artery thrombosis model.
    Imura Y; Kiyota Y; Nagai Y; Nishikawa K; Terashita Z
    Thromb Res; 1995 Jul; 79(1):95-107. PubMed ID: 7495108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ticlopidine plus aspirin for coronary thrombosis in Kawasaki disease.
    O'Brien M; Parness IA; Neufeld EJ; Baker AL; Sundel RP; Newburger JW
    Pediatrics; 2000 May; 105(5):E64. PubMed ID: 10799628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of clopidogrel, vapiprost and argatroban on the middle cerebral artery thrombosis in the rat.
    Umemura K; Kawai H; Ishihara H; Nakashima M
    Jpn J Pharmacol; 1995 Mar; 67(3):253-8. PubMed ID: 7630043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The CLASSICS Study: Clopidogrel plus ASA vs. Ticlopidin plus ASA in stent-patients].
    Z Kardiol; 1999 May; 88(5 Suppl):1-4. PubMed ID: 10399252
    [No Abstract]   [Full Text] [Related]  

  • 12. A double-blind randomized comparison of combined aspirin and ticlopidine therapy versus aspirin or ticlopidine alone on experimental arterial thrombogenesis in humans.
    Bossavy JP; Thalamas C; Sagnard L; Barret A; Sakariassen K; Boneu B; Cadroy Y
    Blood; 1998 Sep; 92(5):1518-25. PubMed ID: 9716578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New no-donors with antithrombotic and vasodilating activities, X: Antiplatelet and antithrombotic effects of 3-methylsydnone-5-nitrosimine (RE 2047) in combination with ASA, pentoxifylline, and ticlopidine.
    Rehse K; Ciborski T
    Arch Pharm (Weinheim); 1995 Jan; 328(1):71-8. PubMed ID: 7695475
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The antiaggregating and antithrombotic activity of clopidogrel is potentiated by aspirin in several experimental models in the rabbit.
    Herbert JM; Dol F; Bernat A; Falotico R; Lalé A; Savi P
    Thromb Haemost; 1998 Sep; 80(3):512-8. PubMed ID: 9759636
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition by combined therapy with ticlopidine and aspirin of enhanced platelet aggregation during physical exercise in patients with coronary artery disease.
    Kitai T; Nishikawa M; Tanigawa T; Okinaka T; Wada H; Shiku H; Ikeda Y; Ito M; Isaka N; Nakano T
    Am Heart J; 2001 Aug; 142(2):E1. PubMed ID: 11479480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The antiaggregating and antithrombotic activity of ticlopidine is potentiated by aspirin in the rat.
    Herbert JM; Bernat A; Samama M; Maffrand JP
    Thromb Haemost; 1996 Jul; 76(1):94-8. PubMed ID: 8819259
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ticlopidine for prevention of stroke.
    Med Lett Drugs Ther; 1992 Jul; 34(874):65-6. PubMed ID: 1614367
    [No Abstract]   [Full Text] [Related]  

  • 19. [Antiplatelet effects of combination therapy with low-dose aspirin and ticlopidine in cerebral ischemia].
    Uchiyama S; Tsutsumi Y; Nagayama T; Kobayashi I; Maruyama S
    Rinsho Shinkeigaku; 1989 May; 29(5):579-83. PubMed ID: 2791406
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Correlation between bleeding time and antithrombotic effect of platelet-suppressive agents in rat experimental model.
    Suehiro A; Oura Y; Ueda M; Kakishita E
    Res Commun Chem Pathol Pharmacol; 1994 Feb; 83(2):157-63. PubMed ID: 8202629
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.